Raras
Buscar doenças, sintomas, genes...
Cutis laxa
ORPHA:209CID-11 · EE41.0DOENÇA RARA

Cutis laxa (CL) é uma doença do tecido conjuntivo que pode ser herdada ou adquirida. Ela é caracterizada por uma pele enrugada, frouxa, em excesso e sem elasticidade, que parece estar caída. Geralmente vem acompanhada de problemas nos ossos e no desenvolvimento e, em alguns casos, de problemas graves que afetam vários órgãos e sistemas do corpo. Várias formas diferentes de Cutis laxa hereditária já foram descritas, sendo classificadas de acordo com a forma como são herdadas, o quão afetados os órgãos internos estão, outros problemas que aparecem junto e a gravidade da doença.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Cutis laxa (CL) é uma doença do tecido conjuntivo que pode ser herdada ou adquirida. Ela é caracterizada por uma pele enrugada, frouxa, em excesso e sem elasticidade, que parece estar caída. Geralmente vem acompanhada de problemas nos ossos e no desenvolvimento e, em alguns casos, de problemas graves que afetam vários órgãos e sistemas do corpo. Várias formas diferentes de Cutis laxa hereditária já foram descritas, sendo classificadas de acordo com a forma como são herdadas, o quão afetados os órgãos internos estão, outros problemas que aparecem junto e a gravidade da doença.

Pesquisas ativas
3 ensaios
174 total registrados no ClinicalTrials.gov
Publicações científicas
941 artigos
Último publicado: 2026 Apr 1

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Herança
Autosomal dominant
+3
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
64 sintomas
😀
Face
51 sintomas
❤️
Coração
45 sintomas
🧠
Neurológico
38 sintomas
🧬
Pele e cabelo
31 sintomas
🫃
Digestivo
26 sintomas

+ 200 sintomas em outras categorias

Características mais comuns

Atraso global do desenvolvimento
Suturas cranianas amplas
Crise focal com alteração da consciência
Úmero curto
Pele redundante no pescoço
Exostoses
541sintomas
Sem dados (541)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 541 características clínicas mais associadas, ordenadas por frequência.

Atraso global do desenvolvimentoGlobal developmental delay
Suturas cranianas amplasWide cranial sutures
Crise focal com alteração da consciênciaFocal impaired awareness seizure
Úmero curtoShort humerus
Pele redundante no pescoçoRedundant neck skin

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico941PubMed
Últimos 10 anos200publicações
Pico202152 papers
Linha do tempo
2026Hoje · 2026🧪 2005Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

15 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, Not applicable, X-linked recessive.

GORABRAB6-interacting golginDisease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

CytoplasmGolgi apparatus

MECANISMO DE DOENÇA

Geroderma osteodysplasticum

A rare autosomal recessive disorder characterized by lax, wrinkled skin, joint laxity and a typical face with a prematurely aged appearance. Skeletal signs include severe osteoporosis leading to frequent fractures, malar and mandibular hypoplasia and a variable degree of growth retardation.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
17.6 TPM
Cervix Ectocervix
15.7 TPM
Fibroblastos
14.6 TPM
Ovário
14.3 TPM
Tecido adiposo
13.0 TPM
OUTRAS DOENÇAS (1)
geroderma osteodysplastica
HGNC:25676UniProt:Q5T7V8
SLC2A10Solute carrier family 2, facilitated glucose transporter member 10Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Facilitative glucose transporter required for the development of the cardiovascular system

LOCALIZAÇÃO

Endomembrane systemCytoplasm, perinuclear region

VIAS BIOLÓGICAS (1)
Cellular hexose transport
MECANISMO DE DOENÇA

Arterial tortuosity syndrome

An autosomal recessive disorder characterized by tortuosity and elongation of major arteries, often resulting in death at young age. Other typical features include aneurysms of large arteries and stenosis of the pulmonary artery, in association with facial features and several connective tissue manifestations such as soft skin and joint laxity. Histopathological findings include fragmentation of elastic fibers in the tunica media of large arteries.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
46.3 TPM
Tireoide
27.1 TPM
Fígado
23.1 TPM
Glândula salivar
22.9 TPM
Próstata
20.4 TPM
OUTRAS DOENÇAS (1)
arterial tortuosity syndrome
HGNC:13444UniProt:O95528
FBLN5Fibulin-5Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Essential for elastic fiber formation, is involved in the assembly of continuous elastin (ELN) polymer and promotes the interaction of microfibrils and ELN (PubMed:18185537). Stabilizes and organizes elastic fibers in the skin, lung and vasculature (By similarity). Promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. Vascular ligand for integrin receptors which may play a role in vascular development and remodeling (PubMed:10428823). May act as an adapter th

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Molecules associated with elastic fibresElastic fibre formation
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 1H

An autosomal dominant demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. CMT1H is characterized by peripheral sensorimotor neuropathy with onset usually in adulthood. Affected individuals present with foot deformities, upper or lower limb sensory disturbances, and motor deficits, mainly impaired gait. Rare patients may have hyperelastic skin or develop age-related macular degeneration.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
795.1 TPM
Fibroblastos
292.3 TPM
Artéria coronária
255.6 TPM
Útero
195.1 TPM
Artéria tibial
192.2 TPM
OUTRAS DOENÇAS (7)
macular degeneration, age-related, 3cutis laxa, autosomal recessive, type 1Acutis laxa, autosomal dominant 2Charcot-Marie-Tooth disease, demyelinating, IIA 1H
HGNC:3602UniProt:Q9UBX5
RIN2Ras and Rab interactor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Ras effector protein. May function as an upstream activator and/or downstream effector for RAB5B in endocytic pathway. May function as a guanine nucleotide exchange (GEF) of RAB5B, required for activating the RAB5 proteins by exchanging bound GDP for free GTP

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

MACS syndrome

A complex disorder of elastic tissue characterized by sagging skin and occasionally by life-threatening visceral complications.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
46.5 TPM
Cervix Ectocervix
39.5 TPM
Cervix Endocervix
37.6 TPM
Vagina
35.3 TPM
Tecido adiposo
35.0 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
RIN2 syndrome
HGNC:18750UniProt:Q8WYP3
PYCR1Pyrroline-5-carboxylate reductase 1, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Oxidoreductase that catalyzes the last step in proline biosynthesis, which corresponds to the reduction of pyrroline-5-carboxylate to L-proline using NAD(P)H (PubMed:16730026, PubMed:19648921, PubMed:23024808, PubMed:28258219). At physiologic concentrations, has higher specific activity in the presence of NADH (PubMed:16730026, PubMed:23024808). Involved in the cellular response to oxidative stress (PubMed:16730026, PubMed:19648921)

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Glutamate and glutamine metabolism
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2B

A disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, a general connective tissue weakness, and varying degrees of growth and developmental delay and neurological abnormalities. Patients do not manifest metabolic abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
80.3 TPM
Linfócitos
66.8 TPM
Glândula salivar
38.9 TPM
Pâncreas
38.5 TPM
Estômago
25.9 TPM
OUTRAS DOENÇAS (3)
PYCR1-related de Barsy syndromeautosomal recessive cutis laxa type 2Bgeroderma osteodysplastica
HGNC:9721UniProt:P32322
LTBP1Latent-transforming growth factor beta-binding protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space (PubMed:2022183, PubMed:8617200, PubMed:8939931). Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta (PubMed:15184403, PubMed:8617200, PubMed:8939931). Outcompeted by LRRC32/GARP for

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Molecules associated with elastic fibresTGF-beta receptor signaling activates SMADs
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2E

A form of cutis laxa, a disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, and a general connective tissue weakness. ARCL2E patients present with cutis laxa, inguinal hernia, craniofacial dysmorphology, variable heart defects, and prominent skeletal features including craniosynostosis, short stature, brachydactyly, and syndactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
576.9 TPM
Artéria tibial
380.4 TPM
Artéria coronária
355.1 TPM
Fibroblastos
271.7 TPM
Esôfago - Muscular
88.0 TPM
OUTRAS DOENÇAS (2)
cutis laxa, autosomal recessive, type 2Eautosomal recessive cutis laxa type 1
HGNC:6714UniProt:Q14766
ALDH18A1Delta-1-pyrroline-5-carboxylate synthaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Bifunctional enzyme that converts glutamate to glutamate 5-semialdehyde, an intermediate in the biosynthesis of proline, ornithine and arginine

LOCALIZAÇÃO

MitochondrionMitochondrion matrix

VIAS BIOLÓGICAS (1)
Mitochondrial protein degradation
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 3A

A syndrome characterized by facial dysmorphism with a progeroid appearance, large and late-closing fontanel, cutis laxa, joint hyperlaxity, athetoid movements and hyperreflexia, pre- and postnatal growth retardation, intellectual deficit, developmental delay, and ophthalmologic abnormalities.

OUTRAS DOENÇAS (6)
hereditary spastic paraplegia 9Aautosomal recessive complex spastic paraplegia type 9Bcutis laxa, autosomal dominant 3ALDH18A1-related de Barsy syndrome
HGNC:9722UniProt:P54886
ATP7ACopper-transporting ATPase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi network membraneCell membraneMelanosome membraneEarly endosome membraneCell projection, axonCell projection, dendritePostsynaptic densityCytoplasm, cytosolEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
Detoxification of Reactive Oxygen Species
MECANISMO DE DOENÇA

Menkes disease

An X-linked recessive disorder of copper metabolism characterized by generalized copper deficiency. MNKD results in progressive neurodegeneration and connective-tissue disturbances: focal cerebral and cerebellar degeneration, early growth retardation, peculiar hair, hypopigmentation, cutis laxa, vascular complications and death in early childhood. The clinical features result from the dysfunction of several copper-dependent enzymes. A mild form of the disease has been described, in which cerebellar ataxia and moderate developmental delay predominate.

OUTRAS DOENÇAS (4)
occipital horn syndromeX-linked distal spinal muscular atrophy type 3Menkes diseaseHirschsprung disease
HGNC:869UniProt:Q04656
LTBP4Latent-transforming growth factor beta-binding protein 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space. Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Molecules associated with elastic fibresTGF-beta receptor signaling activates SMADs
MECANISMO DE DOENÇA

Urban-Rifkin-Davis syndrome

A syndrome characterized by disrupted pulmonary, gastrointestinal, urinary, musculoskeletal, craniofacial and dermal development. Clinical features include cutis laxa, mild cardiovascular lesions, respiratory distress with cystic and atelectatic changes in the lungs, and diverticulosis, tortuosity and stenosis at various levels of the intestinal tract. Craniofacial features include microretrognathia, flat midface, receding forehead and wide fontanelles.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
752.6 TPM
Nervo tibial
709.9 TPM
Artéria coronária
541.5 TPM
Útero
513.5 TPM
Vagina
459.0 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
cutis laxa with severe pulmonary, gastrointestinal and urinary anomaliesDuchenne muscular dystrophy
HGNC:6717UniProt:Q8N2S1
ELNElastinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle (By similarity)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (3)
Degradation of the extracellular matrixMolecules associated with elastic fibresElastic fibre formation
MECANISMO DE DOENÇA

Cutis laxa, autosomal dominant, 1

A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. Additional variable clinical features are gastrointestinal diverticula, hernia, and genital prolapse. Rare manifestations are pulmonary artery stenosis, aortic aneurysm, bronchiectasis, and emphysema.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
1681.2 TPM
Artéria coronária
618.0 TPM
Artéria tibial
510.1 TPM
Pulmão
272.8 TPM
Esôfago - Junção
259.6 TPM
OUTRAS DOENÇAS (5)
supravalvular aortic stenosiscutis laxa, autosomal dominant 1autosomal dominant cutis laxaWilliams syndrome
HGNC:3327UniProt:P15502
EFEMP1EGF-containing fibulin-like extracellular matrix protein 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Binds EGFR, the EGF receptor, inducing EGFR autophosphorylation and the activation of downstream signaling pathways. May play a role in cell adhesion and migration. May function as a negative regulator of chondrocyte differentiation. In the olfactory epithelium, it may regulate glial cell migration, differentiation and the ability of glial cells to support neuronal neurite outgrowth

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Molecules associated with elastic fibres
MECANISMO DE DOENÇA

Doyne honeycomb retinal dystrophy

An autosomal dominant, progressive, ocular disorder characterized by yellow-white deposits known as drusen that accumulate beneath the retinal pigment epithelium. With age, drusen increase in size and number, and eventually cause visual symptoms, including decreased visual acuity, metamorphopsia, photophobia, and paracentral scotoma.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
1495.9 TPM
Artéria coronária
856.1 TPM
Artéria tibial
629.6 TPM
Fibroblastos
428.4 TPM
Adipose Visceral Omentum
314.6 TPM
OUTRAS DOENÇAS (4)
cutis laxa, autosomal recessive, type 1dDoyne honeycomb retinal dystrophyobsolete glaucoma 1, open angle, Hjuvenile open angle glaucoma
HGNC:3218UniProt:Q12805
ATP6V1AV-type proton ATPase catalytic subunit ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalytic subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:8463241). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:32001091). In aerobic conditions, invol

LOCALIZAÇÃO

CytoplasmCytoplasm, cytosolCytoplasmic vesicle, secretory vesicleCytoplasmic vesicle, clathrin-coated vesicle membraneLysosome

VIAS BIOLÓGICAS (6)
Insulin receptor recyclingTransferrin endocytosis and recyclingIon channel transportROS and RNS production in phagocytesAmino acids regulate mTORC1
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2D

A form of cutis laxa, a disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, and a general connective tissue weakness. Most ARCL2D patients exhibit severe hypotonia as well as cardiovascular and neurologic involvement.

OUTRAS DOENÇAS (4)
autosomal recessive cutis laxa type 2Ddevelopmental and epileptic encephalopathy 93undetermined early-onset epileptic encephalopathyautosomal recessive cutis laxa type 2, classic type
HGNC:851UniProt:P38606
ATP6V1E1V-type proton ATPase subunit E 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:32001091, PubMed:33065002). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:32001091)

LOCALIZAÇÃO

Apical cell membraneCytoplasmic vesicle, secretory vesicle, synaptic vesicle membraneCytoplasmic vesicle, clathrin-coated vesicle membrane

VIAS BIOLÓGICAS (6)
Insulin receptor recyclingTransferrin endocytosis and recyclingIon channel transportROS and RNS production in phagocytesAmino acids regulate mTORC1
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2C

A form of cutis laxa, a disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, and a general connective tissue weakness. Most ARCL2C patients exhibit severe hypotonia as well as cardiovascular involvement.

OUTRAS DOENÇAS (2)
autosomal recessive cutis laxa type 2Cautosomal recessive cutis laxa type 2, classic type
HGNC:857UniProt:P36543
ATP6V0A2V-type proton ATPase 116 kDa subunit a 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Subunit of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (By similarity). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (By similarity). Essential component of the endosomal pH-s

LOCALIZAÇÃO

Cell membraneEndosome membrane

VIAS BIOLÓGICAS (3)
Insulin receptor recyclingTransferrin endocytosis and recyclingIon channel transport
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2A

A disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, a general connective tissue weakness, and varying degrees of growth and developmental delay and neurological abnormalities. Some affected individuals develop seizures and mental deterioration later in life, whereas the skin phenotype tends to become milder with age. At the molecular level, an abnormal glycosylation of serum proteins is observed in many cases.

OUTRAS DOENÇAS (3)
wrinkly skin syndromeautosomal recessive cutis laxa type 2Aautosomal recessive cutis laxa type 2, classic type
HGNC:18481UniProt:Q9Y487
EFEMP2EGF-containing fibulin-like extracellular matrix protein 2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Plays a crucial role in elastic fiber formation in tissue, and in the formation of ultrastructural connections between elastic laminae and smooth muscle cells in the aorta, therefore participates in terminal differentiation and maturation of smooth muscle cell (SMC) and in the mechanical properties and wall integrity maintenance of the aorta (PubMed:27339457). In addition, is involved in the control of collagen fibril assembly in tissue throught proteolytic activation of LOX leading to cross- li

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (1)
Molecules associated with elastic fibres
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 1B

A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. The clinical spectrum of autosomal recessive cutis laxa is highly heterogeneous with respect to organ involvement and severity. ARCL1B features include emphysema, lethal pulmonary artery occlusion, aortic aneurysm, cardiopulmonary insufficiency, birth fractures, arachnodactyly, and fragility of blood vessels.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
246.3 TPM
Aorta
219.1 TPM
Útero
186.8 TPM
Cervix Ectocervix
185.8 TPM
Cervix Endocervix
176.1 TPM
OUTRAS DOENÇAS (4)
cutis laxa, autosomal recessive, type 1Blethal arteriopathy syndrome due to fibulin-4 deficiencyautosomal recessive cutis laxa type 1familial thoracic aortic aneurysm and aortic dissection
HGNC:3219UniProt:O95967

Variantes genéticas (ClinVar)

320 variantes patogênicas registradas no ClinVar.

🧬 GORAB: NM_152281.3(GORAB):c.-19dup ()
🧬 GORAB: GRCh37/hg19 1q21.1-44(chr1:143932350-249224684)x3 ()
🧬 GORAB: NM_152281.3(GORAB):c.1A>G (p.Met1Val) ()
🧬 GORAB: NM_152281.3(GORAB):c.679del (p.Ala227fs) ()
🧬 GORAB: NM_152281.3(GORAB):c.62-2A>C ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 3,482 variantes classificadas pelo ClinVar.

174
1567
1741
Patogênica (5.0%)
VUS (45.0%)
Benigna (50.0%)
VARIANTES MAIS SIGNIFICATIVAS
ALDH18A1: NM_002860.4(ALDH18A1):c.1702C>T (p.Gln568Ter) [Pathogenic]
EFEMP2: NM_016938.5(EFEMP2):c.1000C>T (p.Pro334Ser) [Uncertain significance]
ALDH18A1: NM_002860.4(ALDH18A1):c.1234G>C (p.Glu412Gln) [Uncertain significance]
ATP7A: NM_000052.7(ATP7A):c.2332A>G (p.Ile778Val) [Uncertain significance]
ALDH18A1: NM_002860.4(ALDH18A1):c.2286G>A (p.Trp762Ter) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 4 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Cutis laxa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

174 ensaios clínicos encontrados, 3 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
348 papers (10 anos)
#1

Case Report: Newly discovered ELN gene mutation in congenital heart disease: case analysis and review.

Frontiers in pediatrics2026

Supravalvular aortic stenosis (SVAS) is a rare left ventricular outflow tract obstruction, most commonly caused by pathogenic variants in ELN. Truncating variants in exons 1-29 typically produce non-syndromic SVAS through elastin haploinsufficiency, whereas C-terminal variants are linked to autosomal dominant cutis laxa. However, clinically and mechanistically well-characterized variants in the distal part of this "stenotic zone," such as exon 28, remain uncommon. We conducted a retrospective family-based case report with standardized clinical evaluation, serial echocardiography, and trio whole-exome sequencing with Sanger confirmation and conservation analysis. A female infant presented at 1 month with severe sinotubular junction narrowing (Z-score -4.8, peak gradient 24 mmHg), severe peripheral pulmonary artery stenosis, a small atrial septal defect, and moderate mitral regurgitation. Her father had severe SVAS with mild PPAS and prior aortic root enlargement, without syndromic features. Trio sequencing identified a novel heterozygous ELN exon 28 frameshift variant, c.1879_1883dup (p.Ala629LeufsTer15), inherited from the father. Ala629 is fully conserved, and the duplication introduces a premature stop codon, consistent with nonsense-mediated decay and elastin haploinsufficiency. At 9 months, SVAS progressed (peak gradient 35 mmHg), while PPAS gradients regressed by >40%. This novel exon 28 ELN frameshift expands the non-syndromic SVAS spectrum and illustrates a characteristic pattern of progressive aortic stenosis with improving PPAS, supporting ELN testing and targeted longitudinal surveillance in similar patients and families.

#2

Abnormal von Willebrand factor multimer pattern without VWF variants in autosomal-recessive cutis laxa type IIA.

Blood vessels, thrombosis &amp; hemostasis2026 Feb

Neurocutaneous disorders due to mitochondrial proline synthesis defects comprise PYCR1-related autosomal recessive cutis laxa (ARCL), ALDH18A1-related ARCL, and ALDH18A1-related autosomal dominant cutis laxa (ADCL). These disorders are characterized by thin, translucent skin with wrinkles (especially on the hands and feet); typical facial characteristics including a triangular face with a progeroid appearance, a broad forehead (prominent-appearing neurocranium due to small viscerocranium), convex nasal ridge, full or sagging cheeks, and pointed chin; moderate-to-severe intellectual disability or mild intellectual disability with additional neurodiverse phenotypes including autism spectrum disorder or attention-deficit/hyperactivity disorder; and pre- and postnatal growth deficiency. Additional features can include joint laxity, congenital hypotonia, progressive increased lower limb reflexes/spasticity, congenital hip dislocation, adducted thumbs, corneal clouding, and lens opacities. The diagnosis of a neurocutaneous disorder due a to mitochondrial proline synthesis defect can be established in a proband with characteristic clinical findings and identification of biallelic ALDH18A1 or PYCR1 pathogenic variants or a de novo ALDH18A1 pathogenic variant associated with ALDH18A1-related ADCL. Treatment of manifestations: Prelingual speech therapy to improve swallowing and speech development; routine treatment of epilepsy; in those with abnormal serum amino acids (low ornithine, citrulline, arginine), supplementation with arginine has been described in a limited number of individuals, but clinical benefit remains to be confirmed; physical therapy for motor delays and spastic diplegia; mobility devices for spastic diplegia; treatment of hip dislocation, scoliosis, and joint contractures per orthopedist; cervical spine fusion for atlantoaxial instability; palate enlargement as needed; correction of diffraction abnormalities and possible surgical correction in those with impaired vision due to clouding; management of hypertension; treatment of other cardiovascular manifestations per cardiologist. Surveillance: Neurologic exam initially every six months then annually; EEG as clinically indicated; brain MRI every ten years or more frequently in those with imaging abnormalities or new neurologic concerns; monitor developmental progress and educational needs every six months initially then annually; assess growth at each visit; assess for orthopedic manifestations every six months until age one year then annually; anterior chamber evaluation to assess for corneal clouding and cataract annually; echocardiogram every three years or more frequently in those with abnormal findings; brain MR angiogram every ten years or more frequently in those with abnormal findings; peak flow measurements or pulmonary function tests every three years beginning at age eight years. Agents/circumstances to avoid: Contact sports; prolonged fasting; activities requiring hyperbaric pressure; aesthetic surgical intervention; activities with high acceleration or that increase the risk for seizures; smoking; sunbathing. Neurocutaneous disorders due to mitochondrial proline synthesis defects are inherited in an autosomal recessive (PYCR1- and ALDH18A1-related ARCL) or an autosomal dominant (ALDH18A1-related ADCL) manner. Autosomal recessive inheritance: The parents of a child with PYCR1- or ALDH18A1-related ARCL are presumed to be heterozygous for a pathogenic variant. If both parents are known to be heterozygous for a pathogenic variant, each sib of an individual with PYCR1- or ALDH18A1-related ARCL has at conception a 25% chance of being affected, a 50% chance of being heterozygous, and a 25% chance of being unaffected and not a carrier. Heterozygous sibs of a proband with PYCR1-related ARCL are asymptomatic. To date, heterozygous carriers of pathogenic variants causative for ALDH18A1-related ARCL are reported to be asymptomatic. Carrier testing for at-risk relatives requires prior identification of the PYCR1 or ALDH18A1 pathogenic variants in the family. Autosomal dominant inheritance: All probands reported to date with ALDH18A1-related ADCL whose parents have undergone molecular genetic testing have the disorder as the result of a de novo ALDH18A1 pathogenic variant. If the ALDH18A1 pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the recurrence risk to sibs is estimated to be 1% because of the possibility of parental gonadal mosaicism. Once the PYCR1 or ALDH18A1 pathogenic variant(s) have been identified in an affected family member, prenatal and preimplantation genetic testing are possible.

#3

Novel MBTPS1 Variants and Cutis Laxa Phenotype in the 8th Reported Case of Spondyloepiphyseal Dysplasia, Kondo-Fu Type.

Clinical genetics2026 Apr

Spondyloepiphyseal dysplasia, Kondo-Fu (SEDKF) type is a rare skeletal dysplasia caused by biallelic variants in MBTPS1. To date, only seven SEDKF cases have been reported in the literature. Here, we report the eighth, a 20-year-old male presenting with severe disproportionate short stature, spondyloepiphyseal dysplasia, and the previously unreported feature of cutis laxa, which led to the clinical suspicion of geroderma osteodysplasica. Whole exome sequencing identified compound heterozygosity for a predicted splicing variant and a complete gene deletion in the patient. Functional validation using RNA splicing assays confirmed aberrant splicing, establishing the molecular diagnosis of SEDKF. This case broadens the clinical and molecular spectrum of MBTPS1-related disorders by presenting a novel combination of variants and phenotypic features.

#4

ATP6V0A2-Related Cutis Laxa: Identification of a Recurrent Exon 16 Deletion With Founder Effect in Southeastern Türkiye and a Novel Frameshift Variant.

American journal of medical genetics. Part A2026 Feb 24

ATP6V0A2-related cutis laxa is a rare autosomal recessive disorder characterized by connective tissue abnormalities, developmental delay, and neurological features. While multiple sequence variants have been reported, exon-level deletions are rarely documented, and their clinical significance remains largely unknown. This study aims to present the clinical and molecular characteristics of a novel frameshift variant and recurrent exon 16 deletions in the ATP6V0A2 gene, to investigate a potential founder effect in southeastern Türkiye, and to contribute to the expanding genotype-phenotype correlation in ATP6V0A2-related cutis laxa. Ten cases from six unrelated families were evaluated. Exome sequencing, clinical exome sequencing, long-range polymerase chain reaction, gel electrophoresis, and haplotype analysis were performed. Variant interpretation followed ACMG and ClinGen guidelines. Clinical features were assessed through physical examination, developmental history, and neuroimaging. A novel homozygous frameshift variant (c.235del, p.Leu79Phefs*13) associated with severe neurological regression was identified in one case. Nine individuals carried a recurrent homozygous 380 bp deletion spanning exon 16 (c.1936-147_2055+113del). In our study, neurological regression-a feature rarely reported in the literature-was noted in two older patients. Haplotype analysis revealed shared homozygous regions in three cases, suggesting a founder effect. This cohort represents the largest reported series of ATP6V0A2-CL cases with exon 16 deletion to date. This study expands the genotypic and phenotypic spectrum of ATP6V0A2-CL and underscores the importance of copy number variation detection in next-generation sequencing-based diagnostics. The identification of a recurrent exon 16 deletion and shared haplotypes provides evidence for a founder effect in southeastern Türkiye and supports the implementation of population-specific screening for this variant.

#5

Beyond the genome: a rare case report of cutis laxa.

AME case reports2026

Cutis laxa is a heterogeneous group of rare connective tissue pathologies characterized by dermal flaccidity and diminished cutaneous elasticity, often associated with phenotypic features of premature aging. The inherited variants of cutis laxa have various modes of genetic transmission and phenotypic heterogeneity and are categorized into three main categories based on inheritance patterns: autosomal dominant, autosomal recessive, and X-linked recessive forms. Autosomal recessive cutis laxa type 1B (ARCL1B) is associated with the gene EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2). We present a rare case report of cutis laxa in a male infant weighing 2 kg, who was delivered at 33 weeks' gestational age through an emergency grade 1 cesarean. The neonate was hypotonic with poor respiratory effort and cyanosed. He had dysmorphic features, small eyes, loose folds, and sagging, inelastic, and droopy skin. The abdomen was soft with a massive inguinal hernia, and the genitalia were not visible. Multiple limb deformities were also observed, including in utero fractures of the ribs and the long bones, a healed left femur fracture with callus formation, a healing fracture of the left 7th posterior rib, and right angular rib fractures. The neonate showed a small atrial septal defect with left-to-right shunting, severe right atrial enlargement and moderate left atrial enlargement, and severe tricuspid regurgitation. Mechanical ventilation, with escalated high-frequency oscillation and inhaled nitric oxide with a fraction of inspired oxygen of 100% oxygen, was performed, in addition to administering epinephrine, dobutamine, and hydrocortisone. Whole-exome sequencing detected ARCL1B. However, the neonate's status deteriorated, and he eventually succumbed at nine days of age. This case report and literature review highlights the occurrence of an extremely rare case, underscoring the significance of a multidisciplinary approach and prenatal detection to diagnose and manage such a rare case, aiming to contribute to the existing literature.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC614 artigos no totalmostrando 194

2025

Arteriopathies: Too big to be true.

Annals of pediatric cardiology
2026

Monoclonal gammopathies of cutaneous significance: A nomenclature and pathophysiology-based classification.

Journal of the American Academy of Dermatology
2026

ATP6V0A2-Related Cutis Laxa: Identification of a Recurrent Exon 16 Deletion With Founder Effect in Southeastern Türkiye and a Novel Frameshift Variant.

American journal of medical genetics. Part A
2026

Case Report: Newly discovered ELN gene mutation in congenital heart disease: case analysis and review.

Frontiers in pediatrics
2026

Beyond the genome: a rare case report of cutis laxa.

AME case reports
2026

Idiopathic Localized Acquired Cutis Laxa in an Adult Male: A Case Report.

Cureus
2026

Abnormal von Willebrand factor multimer pattern without VWF variants in autosomal-recessive cutis laxa type IIA.

Blood vessels, thrombosis &amp; hemostasis
2026

Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis.

The Journal of dermatology
2026

Cutis Laxa and Basilar Predominant Emphysema.

Radiology. Cardiothoracic imaging
2026

Cutis laxa associated with a missense variant in elastin gene.

JAAD case reports
2025

Cutis laxa syndrome with ascending aortic aneurysm in a child: Bentall procedure and subsequent interventional rescue.

Cardiology in the young
2025

Classical complement activation in light and heavy chain deposition disease with acquired cutis laxa and bronchiolitis obliterans: a case report of monoclonal gammopathy of clinical significance.

Frontiers in immunology
2026

A proposed nosology of inherited disorders of the extracellular matrix (ECM): Insights from the IEMbase and dyadic classification.

Molecular genetics and metabolism
2025

Coexisting elastosis perforans serpiginosa and acquired cutis laxa following long-term penicillamine in Wilson disease.

Skin health and disease
2025

Rare Genetic Variants Underlying Primary Immunodeficiency: Clinical, Pulmonary, and Genetic Insights from Two Pediatric Cases.

Genes
2025

Addressing unmet needs in pregnancy and family planning of people living with rare and low-prevalence diseases: results of the "ERN transversal working group on pregnancy and family planning" survey.

Reproductive health
2025

Design and analysis of a GaN-based 2D photonic crystal biosensor integrated with machine learning techniques for detection of skin diseases.

Scientific reports
2025

Mendelian causes of early-onset emphysema: a review of the current literature.

European respiratory review : an official journal of the European Respiratory Society
2025

Safety of penicillamine and trientine in the treatment of Wilson's disease: An analysis of the FDA Adverse Event Reporting System (FAERS) database.

PloS one
2025

ATP6AP2-Related Disease Caused by Splicing Defects: Abnormal Glycosylation and the First Affected Female.

Journal of inherited metabolic disease
2026

Novel MBTPS1 Variants and Cutis Laxa Phenotype in the 8th Reported Case of Spondyloepiphyseal Dysplasia, Kondo-Fu Type.

Clinical genetics
2025

Novel ATP7A Splice-Site Variant Causing Distal Motor Neuropathy and Occipital Horn Syndrome: Two Siblings and Literature Review.

Genes
2025

Clinical and Oral Manifestations in a Patient with Lenz-Majewski Syndrome: A Rare Case Report.

BMC oral health
2025

Cutis Laxa Type 1 B with Recurrent E57K Variation.

Indian journal of dermatology
2025

The key enzyme PYCR1 in proline metabolism: a dual driver of cancer progression and fibrotic remodeling.

Journal of enzyme inhibition and medicinal chemistry
2025

Clinical and genetic characterization of Lenz-Majewski syndrome with a PTDSS1 variant: a case report and literature review.

Frontiers in pediatrics
2025

Genes associated with genetic and rare lung diseases and the risk of lung cancer.

Research square
2025

Autosomal Recessive Cutis Laxa Type 1C with LTBP4 Mutation: Unmasking an Exceptional Case in the Indian Subcontinent.

Indian dermatology online journal
2025

Multimodal Evaluation of Bethlem Myopathy with the c.788G > A Variant in the COL6A1 Gene: a case report with genetic, ultrasonographic, and structural-functional discordance correlations.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
2025

Successful pre-implantation genetic testing for autosomal recessive cutis laxa: clinical utility of a multidisciplinary team approach.

Journal of assisted reproduction and genetics
2025

A Japanese Case of Lenz-Majewski Syndrome With a Novel PTDSS1 Variant.

Molecular genetics &amp; genomic medicine
2025

Cutis Laxa-Clinically Decoding the Complex Genodermatoses.

Indian dermatology online journal
2025

Two cases with cutis laxa: Two novel variants in the ATP6V0A2 gene and new findings.

Pediatrics international : official journal of the Japan Pediatric Society
2025

Congenital cutis laxa type IC in a newborn with a newly identified genetic variant.

BMJ case reports
2025

Autosomal recessive cutis laxa type 1C with a compound heterozygous frame shift and nonsense LTBP4 variants.

Pediatrics international : official journal of the Japan Pediatric Society
2025

A Shared Pathogenesis? Elastic Tissue Degeneration in Two Generations: Co-Occurrence of Acrokeratoelastoidosis and ARCL1A Cutis Laxa.

Clinical case reports
2025

Case Report: de novo in-frame deletion in PLCG2 gene: a case report of B-cell lymphopenia, pulmonary bullae, and cutis laxa.

Frontiers in immunology
2025

A novel case of autosomal-dominant cutis laxa caused by a de novo likely pathogenic variant in ALDH18A1: case report and literature review.

Journal of human genetics
2025

Toward a rational therapeutic for elastin related disease: Key considerations for elastin based regenerative medicine strategies.

Matrix biology : journal of the International Society for Matrix Biology
2025

Corrigendum: Case report and literature review: delayed diagnosis of ARCL1B due to a newly reported homozygous mutation c.464A>C p. (Tyr155Ser) in the EFEMP2 gene.

Frontiers in genetics
2024

Bilateral lung transplantation for pulmonary emphysema associated with cutis laxa.

JHLT open
2025

Significant Periocular Swelling as a Sign of Systemic Amyloidosis.

Ophthalmic plastic and reconstructive surgery
2025

Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning survey.

Orphanet journal of rare diseases
2025

Correcting Lab Misinterpretations of Variants of Unknown Significance: A Case Study of EMILIN1 Variants in an Autosomal Recessive Disorder.

Cureus
2025

Ocular Manifestations in Congenital Cutis Laxa: A Case Series.

Cornea
2025

De Novo Autosomal Dominant Cutis Laxa Type 3 With Global Developmental Delay and Musculoskeletal Features of Refractory Rickets.

Clinical case reports
2024

Case Report and literature review: Delayed diagnosis of ARCL1B due to a newly reported homozygous mutation c.464A>C p. (Tyr155Ser) in the EFEMP2 gene.

Frontiers in genetics
2024

Successful Reduction of a Dislocated Hip Joint in a Patient With Cutis Laxa From a PYCR1 Mutation: Case Report.

JBJS case connector
2024

Golgi pH elevation due to loss of V-ATPase subunit V0a2 function correlates with tissue-specific glycosylation changes and globozoospermia.

Cellular and molecular life sciences : CMLS
2024

Acquired Cutis Laxa Type 2 (Marshall's Syndrome) Associated with Sweet's Syndrome: A Rare Entity.

Indian journal of dermatology
2025

Acquired generalised cutis laxa with visceral involvement in a patient with rheumatoid arthritis and monoclonal gammopathy of uncertain significance.

Indian journal of dermatology, venereology and leprology
2025

Phenotypic findings associated with variation in elastin.

HGG advances
2024

Case Report: A male newborn with occipital horn syndrome.

F1000Research
2024

Elucidating the roles of SOD3 correlated genes and reactive oxygen species in rare human diseases using a bioinformatic-ontology approach.

PloS one
2024

The first Japanese case of autosomal dominant cutis laxa with a frameshift mutation in exon 30 of the elastin gene complicated by small airway disease with 8 years of follow-up.

BMC pulmonary medicine
2024

Confirming the enzymatic activity and neurodevelopmental trajectory of PYCR1 mutation in one child with autosomal-recessive cutis laxa type 2.

Molecular genetics and genomics : MGG
2024

Effect of decreased expression of latent TGF-β binding proteins 4 on the pathogenesis of emphysema as an age-related disease.

Archives of gerontology and geriatrics
2025

Extreme arterial tortuosity with ascending aortic aneurysm in a child with suspected Cutis Laxa syndrome.

Acta cardiologica
2024

Long-read sequencing identifies an SVA_D retrotransposon insertion deep within the intron of ATP7A as a novel cause of occipital horn syndrome.

Journal of medical genetics
2024

Acquired cutis laxa: a clinical review.

International journal of dermatology
2024

Discovery of pathogenic variants in EFEMP2 and RAG1 and undetectable fetal phenotype: A challenge of prenatal exome sequencing.

Prenatal diagnosis
2024

Penicillamine-Induced Localised Cutis Laxa in a Patient with Wilson Disease: A Case Report.

Mediterranean journal of rheumatology
2024

A Growth-Restricted Neonate with Abnormal Facies and Lax Skin.

NeoReviews
2024

A case of monoclonal gammopathy of cutaneous significance with multiple organs involvement: Comment on "Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia".

The Journal of dermatology
2024

Identification of a novel intronic variant of ATP6V0A2 in a Han-Chinese family with cutis laxa.

Molecular biology reports
2024

Severe atopic dermatitis with cutis laxa caused by a variant in the ELN gene.

JAAD case reports
2024

The Human Mutation K237_V238del in a Putative Lipid Binding Motif within the V-ATPase a2 Isoform Suggests a Molecular Mechanism Underlying Cutis Laxa.

International journal of molecular sciences
2024

Dynamic Reconstruction Using Bilateral Lengthening Temporalis Myoplasty for Facial Palsies in Patients with Hereditary Skin Laxity.

Plastic and reconstructive surgery. Global open
2024

A novel intronic variant of ATP6V0A2-related cutis laxa with impaired cognitive function.

Pediatrics and neonatology
2024

Type I acquired cutis laxa: Report of a unique progressive case and short review.

The American journal of the medical sciences
2024

Lenz-Majewski syndrome and recurrent otitis media: Are they related or not?

European journal of medical genetics
2023

Corkscrew Mesenteric Arteries and Tortuous Descending Aorta in Autosomal Recessive Cutis Laxa.

Radiology. Cardiothoracic imaging
2024

Deep intronic variant causes aberrant splicing of ATP7A in a family with a variable occipital horn syndrome phenotype.

European journal of medical genetics
2023

[Lipomatous hypertrophy of the interatrial septum].

Medicina
2024

Free Dermal Fat Grafting: A Novel Technique for the Correction of Nasolabial Folds During Facelift Surgery.

Aesthetic surgery journal
2023

Expanding the phenotype and metabolic basis of ATP6AP2-congenital disorder of glycosylation in a Chinese patient with a novel variant c.185G>A (p.Gly62Glu).

Frontiers in genetics
2023

Comprehensive review of aortic aneurysms, dissections, and cardiovascular complications in connective tissue disorders.

Medicine
2023

Giant ascending aortic aneurysm with impending rupture as presentation of cutis laxa 1B: a case report.

European heart journal. Case reports
2023

Novel mutation in ELN gene causes cardiac abnormalities and inguinal hernia: case report.

BMC pediatrics
2024

A rare case of secondary cutaneous lymphoplasmacytic lymphoma clinically presenting as acquired cutis laxa.

Journal of cutaneous pathology
2024

Visceral adiposity in patients with lipomatous hypertrophy of the interatrial septum.

Heart and vessels
2024

Complete resolution of generalized annular elastolytic giant cell granuloma with doxycycline.

Anais brasileiros de dermatologia
2022

18F-FDG PET/CT helps rule out malignancy in lipomatous hypertrophy of the interatrial septum with atypical MRI manifestations, to avoid unnecessary surgical treatment.

The international journal of cardiovascular imaging
2023

Atlantoaxial instability associated with ALDH18A1 mutation.

American journal of medical genetics. Part A
2024

ATP6V1A variants are associated with childhood epilepsy with favorable outcome.

Seizure
2023

A case of cutis verticis gyrata developing in a patient with primary scarring alopecia: A unique presentation of a rare disorder.

JAAD case reports
2023

Wells syndrome and acquired cutis laxa: An atypical association.

The Journal of dermatology
2023

Characterization of the Zebrafish Elastin a (elnasa12235) Mutant: A New Model of Elastinopathy Leading to Heart Valve Defects.

Cells
2023

Progressive Generalized Skin Laxity in a Young Woman.

JAMA dermatology
2024

Acquired cutis laxa secondary to acute generalized exanthematous pustulosis: A case report and mini-review of literature.

The Journal of dermatology
2023

Two novel homozygous variants of ATP6V0A2 and ALDH18A1 lead to autosomal recessive cutis laxa type 2 and 3 in two Pakistani families.

The journal of gene medicine
2023

Neonatal presentation of occipital horn syndrome caused by a ATP7A missense variant.

Journal of inherited metabolic disease
2023

Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia.

The Journal of dermatology
2023

Surgical Management of Hip Dislocation in a Patient with SCARF Syndrome: A Case Report with a 6-Year Follow-up.

JBJS case connector
2023

Cutis Laxa and the Value of Rhytidectomy: 4 Patients and Years of Follow-Up.

The Journal of craniofacial surgery
2023

Clinical features in adults with acquired cutis laxa: a retrospective review.

The British journal of dermatology
2023

FBLN5-Related Cutis Laxa Syndrome: A Case with a Novel Variant and Review of the Literature.

Molecular syndromology
2023

De Barsy Syndrome: A Case Report of a Rare Genetic Disorder.

Cureus
2023

Papillary dermal elastolysis histopathology mimicking folliculotropic mycosis fungoides.

Journal of cutaneous pathology
2024

NOVEL RETINAL FINDINGS IN A PATIENT WITH AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2A.

Retinal cases &amp; brief reports
2023

ATP7A-related copper transport disorders: A systematic review and definition of the clinical subtypes.

Journal of inherited metabolic disease
2022

Spontaneous coronary artery dissection in cutis laxa.

BJR case reports
2023

Supravalvular aortic stenosis with bicuspid aortic valve in a patient with cutis laxa syndrome.

QJM : monthly journal of the Association of Physicians
2023

Autosomal dominant cutis laxa and critical stenosis of the left main coronary artery in a 21-year-old female with an intronic mutation in the elastin gene.

American journal of medical genetics. Part A
2023

Progeroid syndrome of De Barsy - a case report and review of ophthalmic literature.

Ophthalmic genetics
2023

A novel deletion mutation in the ATP6V0A2 gene in an Iranian patient affected by autosomal recessive cutis laxa.

Irish journal of medical science
2022

Autosomal recessive cutis laxa type Ib-Successful redo aortic root and arch replacement.

Clinical case reports
2022

Acquired cutis laxa from heavy chain deposition disease.

Kidney international
2022

EMILIN1 deficiency causes arterial tortuosity with osteopenia and connects impaired elastogenesis with defective collagen fibrillogenesis.

American journal of human genetics
2022

Acquired Cutis Laxa in a Patient with Type I Diabetes and Renal Failure under Immunosuppressive Therapy for Transplantation.

Indian dermatology online journal
2022

[Analysis of clinical features and genetic variants in a child with autosomal recessive cutis laxa due to variants of ATP6V0A2 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Functional assessment of homozygous ALDH18A1 variants reveals alterations in amino acid and antioxidant metabolism.

Human molecular genetics
2022

Identification of a de novo mutation of the elastin gene by targeted exome sequencing in autosomal dominant cutis laxa.

Clinical and experimental dermatology
2022

First report of a short in-frame biallelic deletion removing part of the EGF-like domain calcium-binding motif in LTBP4 and causing autosomal recessive cutis laxa type 1C.

American journal of medical genetics. Part A
2022

Successful surgical intervention for giant thoracic aortic aneurysm in cutis laxa aortopathy.

JTCVS techniques
2022

[Sweet syndrome of childhood with acquired cutis laxa (Marshall syndrome) as primary manifestation of Takayasu arteritis].

Dermatologie (Heidelberg, Germany)
2022

Autosomal recessive cutis laxa type IIIA: Report of a patient with severe phenotype and review of the literature.

European journal of medical genetics
2022

Acquired Cutis Laxa on the Upper Eyelids and Earlobes: A Case Report and Literature Review.

Archives of plastic surgery
2022

The response to growth hormone treatment in a child with short stature, growth hormone deficiency and autosomal dominant cutis laxa type 3 - case report.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2022

Lipomatous Hypertrophy of the Atrial Septum.

Deutsches Arzteblatt international
2022

Autosomal recessive cutis laxa type 1C with a homozygous LTBP4 splicing variant: a case report and update of literature.

Molecular biology reports
2022

Identification of a Novel Deep Intronic Variant by Whole Genome Sequencing Combined With RNA Sequencing in a Chinese Patient With Menkes Disease.

Frontiers in genetics
2022

Clinical commentary about foreign body complications over 20 years after polymethyl-methacrylate face implants and control of late sequelae with Polynucleotides Highly Purified Technology (PN-HPT® ).

Journal of cosmetic dermatology
2022

Congenital Cutis Laxa: A Case Report and Literature Review.

Frontiers in surgery
2022

Familial Michelin tire baby syndrome.

The Journal of dermatology
2023

Clinical and electrophysiological findings of facial palsy in a case of hereditary gelsolin amyloidosis.

Auris, nasus, larynx
2022

Author Correction: Mutations in PYCR1 cause cutis laxa with progeroid features.

Nature genetics
2021

Giant Aortic Aneurysm in Child with Cutis Laxa Syndrome: Unusual Presentation, New Surgical Technique.

The heart surgery forum
2022

Expanding the phenotypic spectrum of ALDH18A1-related autosomal recessive cutis laxa with a description of novel neuroradiological findings.

Clinical dysmorphology
2021

A novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation.

Computational and structural biotechnology journal
2022

Acquired cutis laxa type II (Marshall syndrome) in a 3-month-old boy.

Pediatric dermatology
2021

The Role of Cardiovascular Surgery in the Management of a Patient Diagnosed With Congenital Cutis Laxa Syndrome Complicated by Multivalvular Heart Disease.

Cureus
2021

Case Report: Occurrence of Severe Thoracic Aortic Aneurysms (Involving the Ascending, Arch, and Descending Segments) as a Result of Fibulin-4 Deficiency: A Rare Pathology With Successful Management.

Frontiers in cardiovascular medicine
2022

Major response to adalimumab in patient with Sweet syndrome associated to an acquired cutis laxa.

Journal of the European Academy of Dermatology and Venereology : JEADV
2021

Bi-allelic premature truncating variants in LTBP1 cause cutis laxa syndrome.

American journal of human genetics
2021

Hemopericardium with cardiac tamponade as a rare presentation of a massive aortic aneurysm in a young child with autosomal recessive cutis laxa.

Echocardiography (Mount Kisco, N.Y.)
2021

Clinical and Molecular Delineation of Cutis Laxa Syndromes: Paradigms for Homeostasis.

Advances in experimental medicine and biology
2021

Basic Components of Connective Tissues and Extracellular Matrix: Fibronectin, Fibrinogen, Laminin, Elastin, Fibrillins, Fibulins, Matrilins, Tenascins and Thrombospondins.

Advances in experimental medicine and biology
2022

Pseudoxanthoma Elasticum With Cutis Laxa-Like Features.

JAMA dermatology
2022

Severe cutis laxa caused by immunoglobulin M gammopathy.

British journal of haematology
2021

Severe ocular involvement in hereditary gelsolin amyloidosis.

Porto biomedical journal
2022

Chronic urticaria may not be as innocent as we think: A rare case of acquired cutis laxa following chronic urticaria.

Journal of cosmetic dermatology
2022

Woolly hair nevus caused by somatic mutation and Costello syndrome caused by germline mutation in HRAS: Consider parental mosaicism in prenatal counseling.

The Journal of dermatology
2021

Autosomal Recessive Cutis Laxa 1C Mutations Disrupt the Structure and Interactions of Latent TGFβ Binding Protein-4.

Frontiers in genetics
2021

B3GAT3-related linkeropathy and an in-frame homozygous deletion in an adult patient.

European journal of medical genetics
2021

Generalized acquired cutis laxa and urticarial dermatosis associated with k-chain IgA micromolecular myeloma.

Dermatology reports
2021

Menkes disease diagnosed by a novel ATP7A frameshift mutation in a patient with infantile spasms-a case report.

Translational pediatrics
2021

Neutrophil Extracellular Traps as a Possible Pathomechanism of Generalized Acquired Cutis Laxa Associated with IgA-lamda Monoclonal Gammopathy of Undetermined Significance.

Acta dermato-venereologica
2021

Two fetuses in one family of arterial tortuosity syndrome: prenatal ultrasound diagnosis.

BMC pregnancy and childbirth
2021

Cutis laxa after Mariana dam disaster in Brazil.

European review for medical and pharmacological sciences
2021

Clinical and biochemical footprints of inherited metabolic diseases. VI. Metabolic dermatoses.

Molecular genetics and metabolism
2021

Identification of two novel de novo TUBB variants in cases with brain malformations: case reports and literature review.

Journal of human genetics
2021

Loss of zebrafish atp6v1e1b, encoding a subunit of vacuolar ATPase, recapitulates human ARCL type 2C syndrome and identifies multiple pathobiological signatures.

PLoS genetics
2021

Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes.

The Journal of clinical endocrinology and metabolism
2021

LTBP4 in Health and Disease.

Genes
2021

Normal transferrin patterns in congenital disorders of glycosylation with Golgi homeostasis disruption: apolipoprotein C-III at the rescue!

Clinica chimica acta; international journal of clinical chemistry
2021

A novel GSN variant outside the G2 calcium-binding domain associated with Amyloidosis of the Finnish type.

Human mutation
2021

Clinical Features and Brain MRI Findings in Korean Patients with AGel Amyloidosis.

Yonsei medical journal
2021

Copper Toxicity Associated With an ATP7A-Related Complex Phenotype.

Pediatric neurology
2021

Severe congenital cutis laxa: Identification of novel homozygous LOX gene variants in two families.

Clinical genetics
2021

Loss-of-Function Variants in EFEMP1 Cause a Recognizable Connective Tissue Disorder Characterized by Cutis Laxa and Multiple Herniations.

Genes
2020

[Living with cutis laxa].

La Revue du praticien
2021

Genetic analysis of Pycr1 and Pycr2 in mice.

Genetics
2021

SPG9A with the new occurrence of an ALDH18A1 mutation in a CMT1A family with PMP22 duplication: case report.

BMC neurology
2021

Bioenergetic analysis of aged-phenotype skin in a rare syndromic cutis laxa.

Journal of cosmetic dermatology
2021

New insight into clinical heterogeneity and inheritance diversity of FBLN5-related cutis laxa.

Orphanet journal of rare diseases
2021

Clinical and Histopathological Features of Gelsolin Amyloidosis Associated with a Novel GSN Variant p.Glu580Lys.

International journal of molecular sciences
2021

Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons.

Journal of translational autoimmunity
2021

Review of clinical and molecular variability in autosomal recessive cutis laxa 2A.

American journal of medical genetics. Part A
2020

A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies.

The application of clinical genetics
2021

A proposal of rehabilitative approach in the rare disease "De Barsy Syndrome": case report.

La Clinica terapeutica
2021

Expanding the clinical and molecular spectrum of ATP6V1A related metabolic cutis laxa.

Journal of inherited metabolic disease
2020

Two novel compound heterozygous variants of LTBP4 in a Chinese infant with cutis laxa type IC and a review of the related literature.

BMC medical genomics
2021

Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa.

Molecular genetics &amp; genomic medicine
2020

Overview of the Pulmonary Manifestations in Patients with Autosomal Recessive Cutis Laxa Type IC.

Pediatric allergy, immunology, and pulmonology
2021

Pulmonary Manifestations of Skin Disorders in Children.

Pediatric clinics of North America
2021

Acquired cutis laxa associated with neutrophilic urticarial dermatosis.

International journal of dermatology
2020

ATP7A mutation with occipital horns and distal motor neuropathy: A continuum.

European journal of medical genetics
2021

Successful treatment of acquired cutis laxa with urticarial eruption by diphenyl sulfone.

Clinical and experimental dermatology
2021

Cutis laxa: A comprehensive overview of clinical characteristics and pathophysiology.

Clinical genetics
2020

Six-year follow-up of a survivor of cervical spine fracture and dislocation with oesophageal perforation following long scarf syndrome - a case report and literature review.

BMC musculoskeletal disorders
2021

Dysregulated assembly of elastic fibers in fibulin-5 knockout mice results in a tendon-specific increase in elastic modulus.

Journal of the mechanical behavior of biomedical materials
2021

GGCX mutations in a patient with overlapping pseudoxanthoma elasticum/cutis laxa-like phenotype.

The British journal of dermatology
2021

The fibrillin microfibril/elastic fibre network: A critical extracellular supramolecular scaffold to balance skin homoeostasis.

Experimental dermatology
2020

Infliximab for the treatment of recalcitrant bullous Sweet syndrome in a 10-year-old girl.

Pediatric dermatology
2020

Predominant Motor Delay as a Major Presenting Clinical Sign in Cutis Laxa- Report of a Case with Review of Literature.

Neurology India
2021

Tremor as an early sign of hereditary spastic paraplegia due to mutations in ALDH18A1.

Brain &amp; development
2020

Pathophysiology of premature aging characteristics in Mendelian progeroid disorders.

European journal of medical genetics
2021

Homozygous deletion of MYADML2 in cranial asymmetry, reduced bone maturation, multiple dislocations, lumbar lordosis, and prominent clavicles.

Journal of human genetics
2021

Fractional Carbon Dioxide Laser Treatment for Textural Improvement and Symptomatic Relief of Acquired Cutis Laxa of the Neck.

Lasers in surgery and medicine
2020

Mutations in ATP6V1E1 or ATP6V1A Cause Autosomal-Recessive Cutis Laxa.

American journal of human genetics
2020

Cutis laxa-like calcinosis cutis secondary to asfotase alfa in juvenile-onset hypophosphatasia.

Clinical and experimental dermatology
2021

Postinflammatory cutis laxa in a child.

Archives of disease in childhood
2020

Skin wrinkling of the upper arms: a case of mid-dermal elastolysis.

Dermatology online journal
Ver todos os 614 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

IJCVerificada

Pioneiro da triagem neonatal na América Latina (1976). 17 milhões de bebês triados.

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Cutis laxa

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Case Report: Newly discovered ELN gene mutation in congenital heart disease: case analysis and review.
    Frontiers in pediatrics· 2026· PMID 41695747mais citado
  2. Abnormal von Willebrand factor multimer pattern without VWF variants in autosomal-recessive cutis laxa type IIA.
    Blood vessels, thrombosis &amp; hemostasis· 2026· PMID 41573103mais citado
  3. Novel MBTPS1 Variants and Cutis Laxa Phenotype in the 8th Reported Case of Spondyloepiphyseal Dysplasia, Kondo-Fu Type.
    Clinical genetics· 2026· PMID 41024587mais citado
  4. ATP6V0A2-Related Cutis Laxa: Identification of a Recurrent Exon 16 Deletion With Founder Effect in Southeastern T&#xfc;rkiye and a Novel Frameshift Variant.
    American journal of medical genetics. Part A· 2026· PMID 41732832mais citado
  5. Beyond the genome: a rare case report of cutis laxa.
    AME case reports· 2026· PMID 41676178mais citado
  6. Genes associated with genetic and rare lung diseases and the risk of lung cancer.
    BMC Cancer· 2026· PMID 41917862recente
  7. PTDSS1-Related Lenz-Majewski Hyperostotic Dysplasia.
    · 1993· PMID 41818602recente
  8. Arteriopathies: Too big to be true.
    Ann Pediatr Cardiol· 2025· PMID 41743534recente
  9. Monoclonal gammopathies of cutaneous significance: A nomenclature and pathophysiology-based classification.
    J Am Acad Dermatol· 2026· PMID 41740896recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:209(Orphanet)
  2. MONDO:0016175(MONDO)
  3. GARD:6227(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q2735907(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Cutis laxa
Compêndio · Raras BR

Cutis laxa

ORPHA:209 · MONDO:0016175
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive, Not applicable, X-linked recessive
CID-11
Ensaios
3 ativos
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0010495
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades